On September 26, 2024, Retractable Technologies, Inc. (RVP) filed a complaint in the United States Court of International Trade. The lawsuit targets the United States of America, the Office of the United States Trade Representative, and other defendants involved in the issuance of a 100% tariff on syringes and needles imported from China, effective September 27, 2024.
RVP is seeking preliminary injunctions and a decision to set aside the tariffs, along with certain costs and fees. The company alleges that the most recent tariff review was not properly conducted for needles and syringes, and that the tariffs would cause irreparable harm without sufficient time to increase domestic production.
The complaint details the history of tariff reviews and decisions since 2018, asserting procedural and policy irregularities. This legal action underscores the material financial impact the new tariff policy is expected to have on Retractable Technologies' operations.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.